Metabolic effects of ghrelin and its potential implications in uremia

Kojima, 1999, Ghrelin is a growth-hormone releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 Tschop, 2000, Ghrelin induces adiposity in rodents, Nature, 407, 908, 10.1038/35038090 Nakazato, 2001, A role of ghrelin in the central regulation of feeding, Nature, 409, 194, 10.1038/35051587 Wren, 2001, Ghrelin causes hyperphagia and obesity in rats, Diabetes, 50, 2540, 10.2337/diabetes.50.11.2540 Wren, 2001, Ghrelin enhances appetite and increases food intake in humans, J Clin Endocrinol Metab, 86, 5992, 10.1210/jc.86.12.5992 Shintani, 2001, Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway, Diabetes, 50, 227, 10.2337/diabetes.50.2.227 Ariyasu, 2001, Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans, J Clin Endocrinol Metab, 86, 4753, 10.1210/jc.86.10.4753 Saad, 2002, Insulin regulates plasma ghrelin concentration, J Clin Endocrinol Metab, 87, 3997, 10.1210/jc.87.8.3997 Ishii, 2002, Role of ghrelin in streptozotocin-induced diabetic hyperphagia, Endocrinology, 143, 4934, 10.1210/en.2002-220612 Reimer, 2003, Dose-dependent inhibition by ghrelin of insulin secretion in the mouse, Endocrinology, 144, 916, 10.1210/en.2002-220819 Broglio, 2003, Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans, J Clin Endocrinol Metab, 88, 4268, 10.1210/jc.2002-021940 Anderwald, 2003, Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients, Diabetes, 52, 1792, 10.2337/diabetes.52.7.1792 Barazzoni, 2003, Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rat, Gastroenterology, 124, 1188, 10.1016/S0016-5085(03)00281-6 Choi, 2003, The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis, Endocrinology, 144, 754, 10.1210/en.2002-220783 Thompson, 2004, Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor, Endocrinology, 145, 234, 10.1210/en.2003-0899 Tschop, 2001, Circulating ghrelin levels are decreased in human obesity, Diabetes, 50, 707, 10.2337/diabetes.50.4.707 Nedvidkova, 2003, Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa, J Clin Endocrinol Metab, 88, 1678, 10.1210/jc.2002-021669 Cummings, 2002, Plasma ghrelin levels after diet-induced weight loss or gastric by-pass surgery, N Engl J Med, 346, 1623, 10.1056/NEJMoa012908 Hansen, 2002, Weight loss increases circulating levels of ghrelin in human obesity, Clin Endocrinol, 56, 203, 10.1046/j.0300-0664.2001.01456.x Sturm, 2003, Appetite, food intake, and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women, J Clin Endocrinol Metab, 88, 3747, 10.1210/jc.2002-021656 Robertson, 2004, Plasma ghrelin response following a period of acute overfeeding in normal weight men, Int J Obes Relat Metab Disord, 28, 727, 10.1038/sj.ijo.0802637 Perreault, 2004, Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice, Int J Obes Relat Metab Disord, 28, 879, 10.1038/sj.ijo.0802640 Dulloo, 1997, Poststarvation hyperphagia and body fat overshooting in humans, Am J Clin Nutr, 65, 717, 10.1093/ajcn/65.3.717 Krssak, 1999, Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans, Diabetologia, 42, 113, 10.1007/s001250051123 Murata, 2002, Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells, J Biol Chem, 277, 5667, 10.1074/jbc.M103898200 Yoshimoto, 2002, Plasma ghrelin and desacyl ghrelin concentrations in renal failure, J Am Soc Nephrol, 13, 2748, 10.1097/01.ASN.0000032420.12455.74 Rodriguez Ayala, 2004, Associations between plasma ghrelin levels and body composition in end-stage renal disease, Nephrol Dial Transplant, 19, 421, 10.1093/ndt/gfg559 O’Sullivan, 2002, Body composition and energy metabolism in chronic renal insufficiency, Am J Kidney Dis, 39, 369, 10.1053/ajkd.2002.30558 Kopple, 1997, McCollum Award Lecture, 1996, Am J Clin Nutr, 65, 1544, 10.1093/ajcn/65.5.1544 Szolkiewicz, 2002, Upregulation of fatty acid synthase gene expression in experimental chronic renal failure, Metabolism, 51, 1605, 10.1053/meta.2002.36302 Smogorzewski, 1988, Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle, Kidney Int, 33, 555, 10.1038/ki.1988.33 He, 2001, Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity, Diabetes, 50, 817, 10.2337/diabetes.50.4.817 DeFronzo, 1981, Insulin resistance in uremia, J Clin Invest, 67, 563, 10.1172/JCI110067 Sarnak, 2003, Cardiovascular complications in chronic kidney disease, Am J Kidney Dis, 41, 11, 10.1016/S0272-6386(03)00372-X Yeun, 2000, C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients, Am J Kidney Dis, 35, 469, 10.1016/S0272-6386(00)70200-9